Illumina Short Interest Down 41.3% in June (ILMN)
Illumina (NASDAQ:ILMN) saw a significant drop in short interest in June. As of June 13th, there was short interest totalling 10,265,824 shares, a drop of 41.3% from the May 30th total of 17,495,888 shares, AR Network reports. Based on an average daily trading volume, of 2,518,211 shares, the short-interest ratio is presently 4.1 days. Currently, 8.1% of the company’s stock are short sold.
In other Illumina news, Director Daniel Bradbury sold 2,100 shares of the stock on the open market in a transaction dated Friday, June 27th. The stock was sold at an average price of $171.65, for a total transaction of $360,465.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Illumina from a “neutral” rating to an “outperform” rating in a research note on Tuesday, June 24th. They now have a $205.00 price target on the stock. Separately, analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Finally, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Illumina presently has a consensus rating of “Buy” and an average target price of $146.71.
Shares of Illumina (NASDAQ:ILMN) opened at 172.70 on Monday. Illumina has a 52 week low of $72.13 and a 52 week high of $183.30. The stock has a 50-day moving average of $162.0 and a 200-day moving average of $146.9. The company has a market cap of $22.175 billion and a price-to-earnings ratio of 120.24.
Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, April 22nd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter last year, the company posted $0.46 earnings per share. Illumina’s revenue was up 27.2% compared to the same quarter last year. Analysts expect that Illumina will post $2.17 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.